Blood Culture Tests Market

The global blood culture tests market is projected to reach USD 8.94 billion by 2031 from USD 6.66 billion in 2026, growing at a CAGR of 6.1% during the forecast period. The adoption of blood culture testing is increasing due to the growing burden of bloodstream infections (BSIs), sepsis, and other systemic bacterial and fungal infections, coupled with the rising need for rapid and accurate pathogen detection. Increasing hospital admissions, surgical procedures, immunocompromised patient populations, and the prevalence of healthcare-associated infections are contributing to higher blood culture testing volumes. Healthcare providers are increasingly emphasizing early diagnosis of bloodstream infections and timely initiation of appropriate antimicrobial therapy to reduce sepsis-related morbidity and mortality.

The competitive landscape of the blood culture tests market is characterized by the presence of established in-vitro diagnostics and microbiology companies, including Waters Corporation (US), bioMérieux (France), Thermo Fisher Scientific, Inc. (US), DiaSorin S.p.A. (Italy), and Danaher Corporation (US), among others. Market competition is centered on improving time to detection, workflow automation, microbial recovery, laboratory efficiency, and integration of blood culture with rapid pathogen identification and susceptibility testing workflows. Companies are focusing on automated blood culture systems, advanced culture media and consumables, molecular diagnostic solutions, and integrated microbiology platforms that enable faster clinical decision-making. Product launches/developments, strategic partnerships, acquisitions, geographic expansions, and expansion of installed instrument bases are also being pursued to strengthen market positions.

To know about the assumptions considered for the study download the pdf brochure

For instance, in June 2026, Waters Corporation (US) announced FDA 510(k) clearance for the BD BACTEC FXI Culture System, a next-generation automated blood culture platform designed for high-throughput microbiology laboratories.

Waters Corporation (US)

Waters Corporation is a leading player in the global blood culture tests market, supported by its strong presence in clinical microbiology and extensive portfolio of blood culture instruments and consumables. The company offers the BD BACTEC blood culture systems, blood culture media, and bottles designed for automated detection of bacterial and fungal growth in blood specimens. It benefits from a large installed base of automated blood culture systems, a broad global distribution network, and long-standing relationships with hospitals, microbiology laboratories, and diagnostic centers. Its focus on laboratory automation, workflow efficiency, microbial recovery, and faster detection of bloodstream infections strengthens its competitive position. In addition, BD’s established microbiology expertise, recurring consumables business, regulatory capabilities, and global commercial presence reinforce its leadership in the blood culture tests market.

bioMérieux (France)

bioMérieux is a leading player in the blood culture tests market, driven by its strong specialization in clinical microbiology and infectious disease diagnostics. The company’s blood culture portfolio is centered on the BACT/ALERT platform, including automated blood culture systems and a broad range of culture bottles for aerobic, anaerobic, pediatric, and other testing requirements. It further benefits from complementary microbiology solutions for microbial identification, antimicrobial susceptibility testing, and molecular diagnostics, enabling laboratories to manage multiple stages of the bloodstream infection diagnostic workflow. Its extensive global installed base, strong presence in hospital microbiology laboratories, and established expertise in infectious disease diagnostics support recurring demand for blood culture consumables. Continued investments in automation, rapid diagnostics, and integrated microbiology workflows, along with its global commercial presence, reinforce the company’s strong competitive position in the blood culture tests market.

Market Ranking

The blood culture tests market is consolidated, with key players namely Waters Corporation (US), bioMérieux (France), Thermo Fisher Scientific, Inc. (US), DiaSorin S.p.A. (Italy), and Danaher Corporation (US) contributing to a major share. Waters Corporation is a leading player in the market, supported by its well-established BD BACTEC portfolio of automated blood culture systems and culture media, extensive installed base, and strong presence across hospital and clinical microbiology laboratories. bioMérieux SA holds a prominent position through its BACT/ALERT blood culture platforms and broad range of culture bottles, complemented by its strong capabilities in microbial identification, antimicrobial susceptibility testing, and molecular diagnostics, enabling integrated workflows for bloodstream infection diagnosis. Thermo Fisher Scientific Inc. maintains a notable presence through its Oxoid microbiology portfolio, including blood culture systems, culture media, and related microbiology solutions supporting the detection and identification of bloodstream pathogens. DiaSorin maintains a strong presence in the blood culture tests market through its integrated microbiology and molecular diagnostics portfolio, leveraging its LIAISON platform and expertise in infectious disease testing to support comprehensive bloodstream infection diagnosis. Danaher strengthens its position in the blood culture tests market through its Beckman Coulter and Cepheid businesses, offering complementary microbiology and molecular diagnostic solutions that enable rapid pathogen detection and streamlined clinical laboratory workflows. These companies benefit from established global distribution networks, large customer and installed bases, strong clinical microbiology expertise, and recurring demand for blood culture consumables.

Related Reports:

Blood Culture Tests Market by Product (Consumables, Instruments), Method (Manual, Automated), Technology (Culture-Based, Molecular, Proteomics), Application (Bacteremia, Fungemia), End User (Hospital, Academic Research), Region - Global Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]